T1	Participants 133 166	African American substance users'
T2	Participants 273 314	African American and White cocaine users.
T3	Participants 458 606	African American (n = 444) and White (n = 403) cocaine abusers participating in one of six randomized clinical trials comparing CM to standard care.
T4	Participants 615 711	African American and White patients who initiated treatment with a cocaine-negative urine sample
T5	Participants 992 1049	Whites who began treatment with a cocaine positive sample
T6	Participants 1173 1245	African Americans who initiated treatment with a cocaine positive sample
T7	Participants 1576 1645	African American patients who are using cocaine upon treatment entry.
